Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | (12) | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Shockwave Medical Inc | SWAV | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 334.75 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 334.75 | 334.75 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 157.00 - 334.90 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 334.75 | USD |
Shockwave Medical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 12.52B | 37.40M | - | 730.23M | 147.28M | 3.94 | 85.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Shockwave Medical News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWAV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 334.15 | 334.90 | 334.10 | 334.66 | 2,064,952 | 0.60 | 0.18% |
| 1 Month | 330.10 | 334.90 | 329.55 | 332.75 | 1,072,350 | 4.65 | 1.41% |
| 3 Months | 256.13 | 334.90 | 249.95 | 323.15 | 1,299,832 | 78.62 | 30.70% |
| 6 Months | 171.33 | 334.90 | 165.93 | 290.53 | 875,034 | 163.42 | 95.38% |
| 1 Year | 275.84 | 334.90 | 157.00 | 264.41 | 736,130 | 58.91 | 21.36% |
| 3 Years | 180.93 | 334.90 | 113.36 | 235.10 | 550,530 | 153.82 | 85.02% |
| 5 Years | 60.37 | 334.90 | 22.01 | 174.92 | 508,720 | 274.38 | 454.50% |
Shockwave Medical Description
| ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries. |
